Biotech raises $40M to test forgotten osteoporosis drug in treatment-resistant breast cancer
February 07, 2022 at 06:30 AM EST
A Columbus pharmaceutical startup has raised $40 million toward reviving a once-abandoned osteoporosis drug to slow progression of treatment-resistant metastatic breast cancer.
